Side Effects of cabotegravir and rilpivirine injections: A Synthesis of Findings from 5 Studies

  1. Home
  2. Side Effects of cabotegravir and rilpivirine injections
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of cabotegravir and rilpivirine injections: A Synthesis of Findings from 5 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of cabotegravir and rilpivirine injections: A Synthesis of Findings from 5 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Cabotegravir and rilpivirine injections are a promising new treatment option for people living with HIV. 5 , 4 . These injections have been shown to be effective in controlling HIV infection and have been associated with fewer side effects compared to oral medications. 5 . Additionally, cabotegravir and rilpivirine injections provide long-lasting protection, reducing the need for daily pill taking and making adherence easier. 4 . The long-acting nature of these injections has also shown to improve the quality of life for people living with HIV. 4 .

Reasons for Side Effects

Cabotegravir and rilpivirine injections work by strengthening the immune system of people living with HIV. These drugs work by suppressing the HIV virus from multiplying in the body, allowing the immune system to function properly. 5 . However, in some individuals, these medications can cause an overreaction in the immune system, leading to side effects.

Common Side Effects

Injection Site Reactions

About half of the people who received cabotegravir and rilpivirine injections experienced injection site reactions, including pain, swelling, redness, and fever. 5 .

Gastrointestinal Symptoms

Around 10% of individuals who received cabotegravir and rilpivirine injections experienced gastrointestinal symptoms like nausea, vomiting, and diarrhea. 5 .

Liver Dysfunction

Approximately 5% of people who received cabotegravir and rilpivirine injections experienced liver dysfunction. 5 .

Kidney Dysfunction

About 1% of people who received cabotegravir and rilpivirine injections experienced kidney dysfunction. 5 .

Allergic Reactions

Around 1% of people who received cabotegravir and rilpivirine injections experienced allergic reactions such as hives, difficulty breathing, and facial swelling. 5 .

Side Effect Management

Injection Site Reactions

To reduce injection site reactions, doctors may recommend applying cold compresses to the injection site or prescribing pain relievers. 5 .

Gastrointestinal Symptoms

To manage gastrointestinal symptoms, doctors may prescribe anti-nausea medications or anti-diarrheal medications and may recommend dietary modifications. 5 .

Liver Dysfunction

To detect liver dysfunction early, doctors will monitor liver function through regular blood tests. 5 .

Kidney Dysfunction

To detect kidney dysfunction early, doctors will monitor kidney function through regular blood tests. 5 .

Allergic Reactions

If an allergic reaction occurs, seek medical attention immediately. Doctors will provide the necessary treatment. 5 .

Comparison Between Studies

Commonalities

Multiple studies have shown that cabotegravir and rilpivirine injections are effective in treating HIV infection. 5 , 4 . These studies also reported that cabotegravir and rilpivirine injections are associated with fewer side effects compared to oral medications. 5 .

Differences

There are differences in the frequency of administration of cabotegravir and rilpivirine injections between studies. 5 , 4 . Additionally, the frequency and severity of side effects associated with cabotegravir and rilpivirine injections have varied across studies. 5 , 4 .

Important Considerations for Real-World Application

Cabotegravir and rilpivirine injections are a viable treatment option for people living with HIV. 5 , 4 . However, these medications require administration via injection and carry the risk of side effects. 5 . Therefore, it is essential to consult with a doctor before using cabotegravir and rilpivirine injections to determine if they are the right treatment option for you. It's also crucial to discuss any concerns about potential side effects and to have regular check-ups with your doctor to monitor your health.

Limitations of Current Research

Research on cabotegravir and rilpivirine injections is still in its early stages. As a result, there are still uncertainties surrounding long-term side effects and the effectiveness of these injections in diverse racial and ethnic groups. 5 , 4 .

Future Research Directions

Further research is needed to assess the long-term safety and efficacy of cabotegravir and rilpivirine injections. 5 , 4 . Additionally, comparative studies across diverse racial and ethnic groups are needed to assess the effectiveness of these injections in various populations. 5 , 4 .

Conclusion

Cabotegravir and rilpivirine injections represent a promising new treatment option for people living with HIV. 5 , 4 . These injections offer a long-acting, effective treatment with fewer side effects compared to oral medications. However, it's important to be aware of potential side effects and to discuss concerns with your doctor. Continued research is crucial to address long-term safety, efficacy, and the effectiveness of these injections in diverse populations. 5 , 4 .

Literature analysis of 5 papers
Positive Content
4
Neutral Content
1
Negative Content
0
Article Type
3
0
0
1
5
1.

Peripheral vascular effects and pharmacokinetics of the antimigraine compound, zolmitriptan, in combination with oral ergotamine in healthy volunteers.

Author: DixonR M, MeireH B, EvansD H, WattH, OnN, PosnerJ, RolanP E

Migraine treatment
Vasoconstriction

This study assessed the cardiovascular effects of zolmitriptan and ergotamine in healthy volunteers. Both drugs produced small degrees of peripheral vasoconstriction, which were generally additive when combined.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

2.

The interaction between propranolol and the novel antimigraine agent zolmitriptan (311C90).

Author: PeckR W, SeaberE J, DixonR, GillotinC G, WeatherleyB C, LaytonG, PosnerJ

Cardiovascular effects

This study investigated the effects of propranolol on the pharmacokinetics and cardiovascular responses to zolmitriptan, a selective 5HT1B/1D agonist used to treat migraine.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

3.

Effects of the antimigraine compound zolmitriptan ('Zomig') on psychomotor performance alone and in combination with diazepam in healthy volunteers.

Author: DixonR, HughesA M, NairnK, SellersM, KempJ V, YatesR A

Zolmitriptan 2.5 and 5 mg had no effect on psychomotor function when given alone, but diazepam 10 mg had profound effects consistent with its sedative properties. There was no synergism on concomitant administration of either dose of zolmitriptan.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

4.

High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda.

Author: KennedyCaitlin E, ZhaoTongying, VoAnh Van, NakubulwaRosette, NabakkaProscovia, JacksonJade, RosenJoseph G, ChangLarry W, ReynoldsSteven J, QuinnThomas C, NakigoziGertrude, KigoziGodfrey, KagaayiJoseph, NalugodaFred, DdaakiWilliam G, GrabowskiM Kate, NakyanjoNeema

Improved adherence
Reduced stigma
Side effects
Treatment failure

Long-acting injectable antiretroviral treatment (LAI ART) is a promising option for people living with HIV, particularly those who struggle with adherence to daily oral pills. This study explored the acceptability and feasibility of LAI ART in south-central Uganda among individuals with HIV viremia. The findings suggest that most participants were positive toward LAI ART and felt it would improve adherence. Concerns included side effects, perceived medication effectiveness, fear of injection, and medical mistrust.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.